How Gastrointestinal Stromal Tumors Medications Work

Gastrointestinal Stromal Tumors (GISTs) are rare tumors that arise from the interstitial cells of Cajal or their precursors in the gastrointestinal tract. The primary treatment for localized GIST is Surgery, which aims to completely resect the tumor.

Medications as an Alternative Treatment Option

For patients with unresectable or metastatic GIST, medications play a crucial role in managing the disease. The main classes of medications used are:

• Tyrosine Kinase Inhibitors (TKIs): These drugs target specific enzymes involved in tumor growth and proliferation. Examples include imatinib, sunitinib, and regorafenib.
• Targeted Therapy: Sunitinib is a targeted therapy that inhibits multiple receptor tyrosine kinases, including KIT and PDGFR.
• Immune Therapy: Interferon-alpha has been used as an immunotherapy agent to treat GIST, although its efficacy is limited compared to TKIs.

The mechanism of action for these medications involves inhibiting the signaling pathways that promote tumor growth and survival. For example, TKIs block the ATP-binding site of the KIT receptor tyrosine kinase, preventing autophosphorylation and downstream signaling events that drive tumor progression.